HB 4844 — ANIMAL EUTHANASIA

ThisNothing requirementcontained mayin bethis satisfiedHB4844 byEngrossed translation- into3 Spanish- andLRB095 distribution18962 RCE 45130 b amendatory Act of the breast95th cancerGeneral summariesAssembly requiredshall bybe Sectioninterpreted 2310-345to ofgrant therulemaking Departmentauthority ofunder Publicany Healthother PowersIllinois andstatute Dutieswhere Lawsuch (20authority ILCSis 2310/2310-345).not otherwise explicitly given.

TheFor information provided by the Departmentpurposes of Publicthis Healthamendatory HB4844Act -of 3the -95th LRB095General 18962Assembly, RCE"rules" 45130is bgiven shallthe includemeaning (i)contained ain statementSection that1-70 mammographyof is the mostIllinois accurateAdministrative methodProcedure forAct, makingand an"agency" earlyand detection"agency ofhead" breastare cancer,given however,the nomeanings diagnosticcontained toolin isSections 100%1-20 effective and (ii)1-25 instructionsof forthe performingIllinois breastAdministrative self-examinationProcedure andAct ato statementthe extent that itsuch isdefinitions importantapply to performagencies aor breastagency self-examinationheads monthly.under the jurisdiction of the Governor.

The Department of Public Health shall investigate the causes of dangerously contagious or infectious diseases, especially when existing in epidemic form, and take means to restrict and suppress the same, and whenever such disease becomes, or threatens to become epidemic, in any locality and the local board of health or local authorities neglect or refuse to enforce efficient measures for its restriction or suppression or to act with sufficient promptness or efficiency, or whenever the local board of health or local authorities neglect or refuse to promptly enforce efficient measures for the restriction or suppression of dangerously contagious or infectious diseases, the Department of Public Health may enforce such measures as it deems necessary to protect the public health, and all necessary expenses so incurred shall be paid by the locality for which services are rendered.

(b) Subject to the provisions of subsection (c), the Department may order a person or group of persons to be quarantined or isolated or may order a place to be closed and made off limits to the public to prevent the probable spread of a dangerously contagious or infectious disease, including HB4844 - 4 - LRB095 18962 RCE 45130 b non-compliant tuberculosis patients, until such time as the condition can be corrected or the danger to the public health eliminated or reduced in such a manner that no substantial danger to the public’s health any longer exists.

Orders for isolation of a person or quarantine of a place to prevent the probable spread of a sexually transmissible disease shall be governed by the provisions of Section 7 of the Illinois Sexually Transmissible Disease Control Act and not this Section.

(c) Except as provided in this Section, no person or a group of persons may be ordered to be quarantined or isolated and no place may be ordered to be closed and made off limits to the public except with the consent of the person or owner of the place or upon the prior order of a court of competent jurisdiction.

The Department may, however, order a person or a group of persons to be quarantined or isolated or may order a place to be closed and made off limits to the public on an immediate basis without prior consent or court order if, in the reasonable judgment of the Department, immediate action is required to protect the public from a dangerously contagious or infectious disease.

In the event of an immediate order issued without prior consent or court order, the Department shall, as soon as practical, within 48 hours after issuing the order, obtain the consent of the person or owner or file a petition requesting a court order authorizing the isolation or quarantine or closure.

When exigent circumstances exist that HB4844 - 5 - LRB095 18962 RCE 45130 b cause the court system to be unavailable or that make it impossible to obtain consent or file a petition within 48 hours after issuance of an immediate order, the Department must obtain consent or file a petition requesting a court order as soon as reasonably possible.

To obtain a court order, the Department, by clear and convincing evidence, must prove that the public’s health and welfare are significantly endangered by a person or group of persons that has, that is suspected of having, that has been exposed to, or that is reasonably believed to have been exposed to a dangerously contagious or infectious disease including non-compliant tuberculosis patients or by a place where there is a significant amount of activity likely to spread a dangerously contagious or infectious disease.

The Department must also prove that all other reasonable means of correcting the problem have been exhausted and no less restrictive alternative exists.

For purposes of this subsection, in determining whether no less restrictive alternative exists, the court shall consider evidence showing that, under the circumstances presented by the case in which an order is sought, quarantine or isolation is the measure provided for in a rule of the Department or in guidelines issued by the Centers for Disease Control and Prevention or the World Health Organization.

Persons who are or are about to be ordered to be isolated or quarantined and owners of places that are or are about to be closed and made off limits to the public shall have the right to counsel.

If a HB4844 - 6 - LRB095 18962 RCE 45130 b person or owner is indigent, the court shall appoint counsel for that person or owner.

Persons who are ordered to be isolated or quarantined or who are owners of places that are ordered to be closed and made off limits to the public, shall be given a written notice of such order.

The written notice shall additionally include the following:

(1) notice of the right to counsel;

(2) notice that if the person or owner is indigent, the court will appoint counsel for that person or owner;

(3) notice of the reason for the order for isolation, quarantine, or closure;

(4) notice of whether the order is an immediate order, and if so, the time frame for the Department to seek consent or to file a petition requesting a court order as set out in this subsection;

and (5) notice of the anticipated duration of the isolation, quarantine, or closure.

(d) The Department may order physical examinations and tests and collect laboratory specimens as necessary for the diagnosis or treatment of individuals in order to prevent the probable spread of a dangerously contagious or infectious disease.

Physical examinations, tests, or collection of laboratory specimens must not be such as are reasonably likely to lead to serious harm to the affected individual.

To prevent the spread of a dangerously contagious or infectious disease, the Department may, pursuant to the provisions of subsection (c) of this Section, isolate or quarantine any person whose refusal of physical examination or testing or collection of laboratory specimens results in uncertainty regarding whether HB4844 - 7 - LRB095 18962 RCE 45130 b he or she has been exposed to or is infected with a dangerously contagious or infectious disease or otherwise poses a danger to the public’s health.

An individual may refuse to consent to a physical examination, test, or collection of laboratory specimens.

An individual shall be given a written notice that shall include notice of the following:

(i) that the individual may refuse to consent to physical examination, test, or collection of laboratory specimens;

(ii) that if the individual consents to physical examination, tests, or collection of laboratory specimens, the results of that examination, test, or collection of laboratory specimens may subject the individual to isolation or quarantine pursuant to the provisions of subsection (c) of this Section;

(iii) that if the individual refuses to consent to physical examination, tests, or collection of laboratory specimens and that refusal results in uncertainty regarding whether he or she has been exposed to or is infected with a dangerously contagious or infectious disease or otherwise poses a danger to the public’s health, the individual may be subject to isolation or quarantine pursuant to the provisions of subsection (c) of this Section;

and (iv) that if the individual refuses to consent to physical examinations, tests, or collection of laboratory specimens and becomes subject to isolation and quarantine as provided in this subsection (d), he or she shall have the right to counsel pursuant to the provisions of subsection (c) of this Section.

To the extent feasible without endangering the public’s health, HB4844 - 8 - LRB095 18962 RCE 45130 b the Department shall respect and accommodate the religious beliefs of individuals in implementing this subsection.

(e) The Department may order the administration of vaccines, medications, or other treatments to persons as necessary in order to prevent the probable spread of a dangerously contagious or infectious disease.

A vaccine, medication, or other treatment to be administered must not be such as is reasonably likely to lead to serious harm to the affected individual.

To prevent the spread of a dangerously contagious or infectious disease, the Department may, pursuant to the provisions of subsection (c) of this Section, isolate or quarantine persons who are unable or unwilling to receive vaccines, medications, or other treatments pursuant to this Section.

An individual may refuse to receive vaccines, medications, or other treatments.

An individual shall be given a written notice that shall include notice of the following:

(i) that the individual may refuse to consent to vaccines, medications, or other treatments;

(ii) that if the individual refuses to receive vaccines, medications, or other treatments, the individual may be subject to isolation or quarantine pursuant to the provisions of subsection (c) of this Section;

and (iii) that if the individual refuses to receive vaccines, medications, or other treatments and becomes subject to isolation or quarantine as provided in this subsection (e), he or she shall have the right to counsel pursuant to the provisions of subsection (c) of this Section.

To the extent HB4844 - 9 - LRB095 18962 RCE 45130 b feasible without endangering the public’s health, the Department shall respect and accommodate the religious beliefs of individuals in implementing this subsection.

(f) The Department may order observation and monitoring of persons to prevent the probable spread of a dangerously contagious or infectious disease.

To prevent the spread of a dangerously contagious or infectious disease, the Department may, pursuant to the provisions of subsection (c) of this Section, isolate or quarantine persons whose refusal to undergo observation and monitoring results in uncertainty regarding whether he or she has been exposed to or is infected with a dangerously contagious or infectious disease or otherwise poses a danger to the public’s health.

An individual may refuse to undergo observation and monitoring.

An individual shall be given written notice that shall include notice of the following:

(i) that the individual may refuse to undergo observation and monitoring;

(ii) that if the individual consents to observation and monitoring, the results of that observation and monitoring may subject the individual to isolation or quarantine pursuant to the provisions of subsection (c) of this Section;

(iii) that if the individual refuses to undergo observation and monitoring and that refusal results in uncertainty regarding whether he or she has been exposed to or is infected with a dangerously contagious or infectious disease or otherwise poses a danger to the public’s health, the individual may be subject to isolation or HB4844 - 10 - LRB095 18962 RCE 45130 b quarantine pursuant to the provisions of subsection (c) of this Section;

and (iv) that if the individual refuses to undergo observation and monitoring and becomes subject to isolation or quarantine as provided in this subsection (f), he or she shall have the right to counsel pursuant to the provisions of subsection (c) of this Section.

(g) To prevent the spread of a dangerously contagious or infectious disease among humans, the Department may examine, test, disinfect, seize, or destroy animals or other related property believed to be sources of infection.

An owner of such animal or other related property shall be given written notice regarding such examination, testing, disinfection, seizure, or destruction.

When the Department determines that any animal or related property is infected with or has been exposed to a dangerously contagious or infectious disease, it may agree with the owner upon the value of the animal or of any related property that it may be found necessary to destroy, and in case such an agreement cannot be made, the animals or related property shall be appraised by 3 competent and disinterested appraisers, one to be selected by the Department, one by the claimant, and one by the 2 appraisers thus selected.

The appraisers shall subscribe to an oath made in writing to fairly value the animals or related property in accordance with the requirements of this Act.

The oath, together with the valuation fixed by the appraisers, shall be filed with the Department and preserved by it.

Upon the appraisal being made, the owner or HB4844 - 11 - LRB095 18962 RCE 45130 b the Department shall immediately destroy the animals by "humane euthanasia" as that term is defined in Section 2.09 of the Humane Care for Animals Act.

Dogs and cats, however, shall be euthanized pursuant to the provisions of the Humane Animal Euthanasia in Animal Shelters Act.

The owner or the Department shall additionally, dispose of the carcasses, and disinfect, change, or destroy the premises occupied by the animals, in accordance with rules prescribed by the Department governing such destruction and disinfection.

Upon his or her failure so to do or to cooperate with the Department, the Department shall cause the animals or related property to be destroyed and disposed of in the same manner, and thereupon the owner shall forfeit all right to receive any compensation for the destruction of the animals or related property.

All final administrative decisions of the Department hereunder shall be subject to judicial review pursuant to the provisions of the Administrative Review Law, and all amendments and modifications thereof, and the rules adopted pursuant thereto.

The term "administrative decision" is defined as in Section 3-101 of the Code of Civil Procedure.

(h) To prevent the spread of a dangerously contagious or infectious disease, the Department, local boards of health, and local public health authorities shall have emergency access to medical or health information or records or data upon the condition that the Department, local boards of health, and local public health authorities shall protect the privacy and HB4844 - 12 - LRB095 18962 RCE 45130 b confidentiality of any medical or health information or records or data obtained pursuant to this Section in accordance with federal and State law.

Additionally, any such medical or health information or records or data shall be exempt from inspection and copying under the Freedom of Information Act.

Other than a hearing for the purpose of this Act, any information, records, reports, statements, notes, memoranda, or other data in the possession of the Department, local boards of health, or local public health authorities shall not be admissible as evidence, nor discoverable in any action of any kind in any court or before any tribunal, board, agency, or person.

The access to or disclosure of any of this information or data by the Department, a local board of health, or a local public authority shall not waive or have any effect upon its non-discoverability or non-admissibility.

Any person, facility, institution, or agency that provides emergency access to health information and data under this subsection shall have immunity from any civil or criminal liability, or any other type of liability that might otherwise result by reason of these actions except in the event of willful and wanton misconduct.

The privileged quality of communication between any professional person or any facility shall not constitute grounds for failure to provide emergency access.

Nothing in this subsection shall prohibit the sharing of information as authorized in Section 2.1 of this Act.

The disclosure of any of this information, records, reports, HB4844 - 13 - LRB095 18962 RCE 45130 b statements, notes, memoranda, or other data obtained in any activity under this Act, except that necessary for the purposes of this Act, is unlawful, and any person convicted of violating this provision is guilty of a Class A misdemeanor.

(i) (A) The Department, in order to prevent and control disease, injury, or disability among citizens of the State of Illinois, may develop and implement, in consultation with local public health authorities, a Statewide system for syndromic data collection through the access to interoperable networks, information exchanges, and databases.

The Department may also develop a system for the reporting of comprehensive, integrated data to identify and address unusual occurrences of disease symptoms and other medical complexes affecting the public’s health.

(B) The Department may enter into contracts or agreements with individuals, corporations, hospitals, universities, not-for-profit corporations, governmental entities, or other organizations, whereby those individuals or entities agree to provide assistance in the compilation of the syndromic data collection and reporting system.

(C) The Department shall not release any syndromic data or information obtained pursuant to this subsection to any individuals or entities for purposes other than the protection of the public health.

All access to data by the Department, reports made to the Department, the identity of HB4844 - 14 - LRB095 18962 RCE 45130 b or facts that would tend to lead to the identity of the individual who is the subject of the report, and the identity of or facts that would tend to lead to the identity of the author of the report shall be strictly confidential, are not subject to inspection or dissemination, and shall be used only for public health purposes by the Department, local public health authorities, or the Centers for Disease Control and Prevention.

Entities or individuals submitting reports or providing access to the Department shall not be held liable for the release of information or confidential data to the Department in accordance with this subsection.

(D) Nothing in this subsection prohibits the sharing of information as authorized in Section 2.1 of this Act.

(j) This Section shall be considered supplemental to the existing authority and powers of the Department and shall not be construed to restrain or restrict the Department in protecting the public health under any other provisions of the law.

(k) Any person who knowingly or maliciously disseminates any false information or report concerning the existence of any dangerously contagious or infectious disease in connection with the Department’s power of quarantine, isolation and closure or refuses to comply with a quarantine, isolation or closure order is guilty of a Class A misdemeanor.

(l) The Department of Public Health may establish and HB4844 - 15 - LRB095 18962 RCE 45130 b maintain a chemical and bacteriologic laboratory for the examination of water and wastes, and for the diagnosis of diphtheria, typhoid fever, tuberculosis, malarial fever and such other diseases as it deems necessary for the protection of the public health.

As used in this Act, "locality" means any governmental agency which exercises power pertaining to public health in an area less than the State.

The terms "sanitary investigations and inspections" and "sanitary practices" as used in this Act shall not include or apply to "Public Water Supplies" or "Sewage Works" as defined in the Environmental Protection Act.

The Department may adopt rules that are reasonable and necessary to implement and effectuate this amendatory Act of the 93rd General Assembly.

93-829, eff.

7-28-04.) Section 10.

The Animal Control Act is amended by changing Section 11 as follows:

(510 ILCS 5/11) (from Ch.

8, par.

361) (Text of Section before amendment by P.A.

95-550) Sec.

11.

When not redeemed by the owner, agent, or caretaker, a dog or cat must be scanned for a microchip.

If a microchip is present, the registered owner must be notified.

After contact has been made or attempted, dogs or cats deemed adoptable by the animal control facility shall be offered for HB4844 - 16 - LRB095 18962 RCE 45130 b adoption, or made available to a licensed humane society or rescue group.

If no placement is available, it shall be humanely dispatched pursuant to the Humane Animal Euthanasia in Animal Shelters Act.

An animal pound or animal shelter shall not release any dog or cat when not redeemed by the owner unless the animal has been rendered incapable of reproduction and microchipped, or the person wishing to adopt an animal prior to the surgical procedures having been performed shall have executed a written agreement promising to have such service performed, including microchipping, within a specified period of time not to exceed 30 days.

Failure to fulfill the terms of the agreement shall result in seizure and impoundment of the animal and any offspring by the animal pound or shelter, and any monies which have been deposited shall be forfeited and submitted to the Pet Population Control Fund on a yearly basis.

This Act shall not prevent humane societies from engaging in activities set forth by their charters;

provided, they are not inconsistent with provisions of this Act and other existing laws.

No animal shelter or animal control facility shall release dogs or cats to an individual representing a rescue group, unless the group has been licensed or has a foster care permit issued by the Illinois Department of Agriculture or is a representative of a not-for-profit out-of-state organization.

The Department may suspend or revoke the license of any animal shelter or animal control facility that fails to comply with the requirements set forth in this Section or that fails to HB4844 - 17 - LRB095 18962 RCE 45130 b report its intake and euthanasia statistics each year.

(Source:

P.A.

93-548, eff.

8-19-03;

94-639, eff.

8-22-05.) (Text of Section after amendment by P.A.

95-550) Sec.

11.

When not redeemed by the owner, agent, or caretaker, a dog or cat must be scanned for a microchip.

If a microchip is present, the registered owner must be notified.

After contact has been made or attempted, dogs or cats deemed adoptable by the animal control facility shall be offered for adoption, or made available to a licensed humane society or rescue group.

If no placement is available, it shall be humanely dispatched pursuant to the Humane Animal Euthanasia in Animal Shelters Act.

An animal pound or animal shelter shall not adopt or release any dog or cat to anyone other than the owner unless the animal has been rendered incapable of reproduction and microchipped, or the person wishing to adopt an animal prior to the surgical procedures having been performed shall have executed a written agreement promising to have such service performed, including microchipping, within a specified period of time not to exceed 30 days.

Failure to fulfill the terms of the agreement shall result in seizure and impoundment of the animal and any offspring by the animal pound or shelter, and any monies which have been deposited shall be forfeited and submitted to the Pet Population Control Fund on a yearly basis.

This Act shall not prevent humane societies from engaging in activities set forth by their charters;

provided, HB4844 - 18 - LRB095 18962 RCE 45130 b they are not inconsistent with provisions of this Act and other existing laws.

No animal shelter or animal control facility shall release dogs or cats to an individual representing a rescue group, unless the group has been licensed or has a foster care permit issued by the Illinois Department of Agriculture or is a representative of a not-for-profit out-of-state organization.

The Department may suspend or revoke the license of any animal shelter or animal control facility that fails to comply with the requirements set forth in this Section or that fails to report its intake and euthanasia statistics each year.

(Source:

P.A.

94-639, eff.

8-22-05;

95-550, eff.

6-1-08.) Section 15.

The Humane Care for Animals Act is amended by changing Section 6 and by adding Section 3.08 as follows:

(510 ILCS 70/3.08 new) Sec.

3.08.

Destruction of companion animal by prohibited method.

Any individual who knowingly or intentionally destroys or authorizes the destruction of a companion animal by any of the following means is guilty of a Class A misdemeanor for the first violation and a Class 4 felony for a second or subsequent violation:

(1) by means of placing the animal in a decompression chamber and lowering the pressure of the oxygen content in the air surrounding the animal;

or HB4844 - 19 - LRB095 18962 RCE 45130 b (2) by use of nitrous oxide, halothane, carbon monoxide, or carbon dioxide.

(510 ILCS 70/6) (from Ch.

8, par.

706) Sec.

6.

Poisoning prohibited.

No person may knowingly poison or cause to be poisoned any dog or other domestic animal.

The only exception will be by written permit from the Department for the purpose of controlling diseases transmissible to humans or other animals and only when all other methods and means have been exhausted.

Such a written permit shall name the person or persons conducting the poisoning, specify the products to be used, give the boundaries of the area involved, and specify the precautionary measures to be employed to insure the safety of humans and other animals.

This Section does not prohibit the use of a euthanasia drug by a euthanasia agency for the purpose of animal euthanasia, provided that the euthanasia drug is used by or under the direction of a licensed veterinarian or certified euthanasia technician, all as defined in and subject to the Humane Animal Euthanasia in Animal Shelters Act.

A person convicted of violating this Section or any rule, regulation, or order of the Department pursuant thereto is guilty of a Class A misdemeanor.

A second or subsequent violation is a Class 4 felony.

(Source:

P.A.

7-11-02.) HB4844(510 -ILCS 2070/3.09 -new) LRB095Sec. 18962 RCE 45130 b Section 20.

The3.09. Humane Euthanasia in Animal Shelters Act is amended by changing Sections 1, 35, 57, 65, and 90 and by adding Sections 36, 66, and 91 as follows:

(510Carbon ILCSmonoxide 72/1)euthanasia Sec.by a licensed veterinarian.

1.A licensed veterinarian may euthanize a companion animal in a commercially manufactured chamber by use of compressed carbon monoxide.

ShortThe title.veterinarian must be physically present during the euthanasia process until death is confirmed.

ThisThe Actveterinarian maymust betake cited as the Humanefollowing Animalsteps Euthanasiawhen inusing Animala Sheltersgas Act.chamber:

(Source:(1) Render a written opinion for each companion animal including the following:

P.A.(A) a description of the animal including species, color, age, sex, and microchip number if present.

92-449,(B) eff.a signed and dated statement that the use of HB4844 Engrossed - 4 - LRB095 18962 RCE 45130 b compressed carbon monoxide is the most humane method of euthanasia for this companion animal.

1-1-02.)(2) (510Use ILCSa 72/35)commercially Sec.manufactured chamber pursuant to the guidelines set forth in the most recent report of the AVMA Panel on Euthanasia.

The interior of the chamber must be well lit and equipped with view-ports, a regulator, and a flow meter.

Monitoring equipment must be used at all times during the operation.

Animals that are under 4 months of age, old, injured, or sick may not be euthanized by carbon monoxide.

Animals shall remain in the chamber and be exposed for a minimum of 20 minutes.

Staff members shall be fully notified of potential health risks.

(3) Only one companion animal may be euthanized at a time.

Section 10.

The Humane Euthanasia in Animal Shelters Act is amended by changing Sections 35, 57, 65, and 90 and by adding Sections 36, 66, and 91 as follows:

(510 ILCS 72/35) Sec.

In determining moral HB4844 Engrossed - 5 - LRB095 18962 RCE 45130 b character under this Section, the Department may take into consideration whether the applicant has engaged in conduct or activities that would constitute grounds for discipline under this Act.

These HB4844 - 21 - LRB095 18962 RCE 45130 b fingerprints shall be checked against the Department of State Police and Federal Bureau of Investigation criminal history record databases now and hereafter filed.

Every 5 years a certified euthanasia technician must renew his or her HB4844 Engrossed - 6 - LRB095 18962 RCE 45130 b certification with the Department.

For a period of 12 months after the adoption of final administrative rules for this Act, the Department may issue a certification to an applicant who holds a license or HB4844 - 22 - LRB095 18962 RCE 45130 b certification from the American Humane Association, the National Animal Control Association, the Illinois Federation of Humane Societies, or the Humane Society of the United States issued after January 1, 1997.

(5) humanely euthanizing animals via intravenous injection by hypodermic needle, intraperitoneal injection HB4844 Engrossed - 7 - LRB095 18962 RCE 45130 b by hypodermic needle, solutions or powder added to food or by mouth, intracardiac injection only on comatose animals by hypodermic needle, or carbon monoxide in a commercially manufactured chamber;

A euthanasia technician may not personally possess, order, or administer a HB4844 - 23 - LRB095 18962 RCE 45130 b controlled substance except as an agent of the euthanasia agency.

(f) Notwithstanding any other rulemaking authority that may exist, neither the Governor nor any agency or agency head under the jurisdiction of the Governor has any authority to make or promulgate rules to implement or enforce the provisions of this amendatory Act of the 95th General Assembly.

If, however, the Governor believes that rules are necessary to implement or enforce the provisions of this amendatory Act of HB4844 Engrossed - 8 - LRB095 18962 RCE 45130 b the 95th General Assembly, the Governor may suggest rules to the General Assembly by filing them with the Clerk of the House and Secretary of the Senate and by requesting that the General Assembly authorize such rulemaking by law, enact those suggested rules into law, or take any other appropriate action in the General Assembly’s discretion.

Nothing contained in this amendatory Act of the 95th General Assembly shall be interpreted to grant rulemaking authority under any other Illinois statute where such authority is not otherwise explicitly given.

For the purposes of this amendatory Act of the 95th General Assembly, "rules" is given the meaning contained in Section 1-70 of the Illinois Administrative Procedure Act, and "agency" and "agency head" are given the meanings contained in Sections 1-20 and 1-25 of the Illinois Administrative Procedure Act to the extent that such definitions apply to agencies or agency heads under the jurisdiction of the Governor.

The Department shall not issue a certificate to any individual convicted in Illinois of a forcible felony, a felony violation of the Humane Care for Animals Act, a felony violation of Article 24 of the Criminal Code of 1961, a felony violation of Class 3 or higher of the Cannabis Control Act, a felony violation of Class 2 or HB4844 Engrossed - 9 - LRB095 18962 RCE 45130 b higher of the Methamphetamine Control and Community Prevention Act, or any violation of Section 12-35 or 26-5 of the Criminal Code of 1961, or convicted in another jurisdiction of the United States of an offense substantially similar to any of the specified Illinois offenses,offenses. for a period of 10 years commencing upon the release of a person from incarceration.

(510 ILCS 72/57) HB4844 - 24 - LRB095 18962 RCE 45130 b Sec.

(a) Only euthanasia drugs and commercially compressed carbon monoxide, subject to the limitations imposed under subsection (b) of this Section, shall be used for the purpose of humanely euthanizing injured, sick, homeless, or unwanted companion animals in an animal shelter or an animal control facility licensed under the Illinois Animal Welfare Act, except that a licensed veterinarian may euthanize companion animals in such a shelter or facility by the use of carbon monoxide if the veterinarian complies with the requirements set forth in Section 3.09 of the Humane Care for Animals Act.

The interior of the chamber must be well lit and HB4844 Engrossed - 10 - LRB095 18962 RCE 45130 b equipped with view-ports, a regulator, and a flow meter.

HB4844 - 25 - LRB095 18962 RCE 45130 b (Source:

HB4844 Engrossed - 11 - LRB095 18962 RCE 45130 b (C) humanely euthanizing animals by intravenous injection by hypodermic needle, intraperitoneal injection by hypodermic needle, solutions or powder added to food or by mouth, intracardiac injection only on comatose animals by hypodermic needle;

HB4844 - 26 - LRB095 18962 RCE 45130 b (4) Abetting anyone in the activities listed in this Section.

HB4844 Engrossed - 12 - LRB095 18962 RCE 45130 b (1) failing to carry out the duties of a euthanasia technician;

HB4844 - 27 - LRB095 18962 RCE 45130 b (Source:

(2) Failing to the maintain the security of all controlled substances and drugs.

(3) Allowing euthanasia to be performed by an individual other than a certified euthanasia technician, a licensed HB4844 Engrossed - 13 - LRB095 18962 RCE 45130 b veterinarian, or an instructor.

(a) A person who practices, offers to practice, attempts to practice, or holds himself or herself out as a certified euthanasia technician or a certified euthanasia agency without HB4844 - 28 - LRB095 18962 RCE 45130 b being certified under this Act shall, in addition to any other penalty provided by law, pay a civil penalty to the Department in an amount not to exceed $5,000 for each offense as determined by the Department.

(c) Instructors or licensed veterinarians teaching humane HB4844 Engrossed - 14 - LRB095 18962 RCE 45130 b euthanasia techniques are exempt from the certification process so long as they are currently licensed by another state as a euthanasia technician or as a veterinarian.

Any violation of Section HB4844 - 29 - LRB095 18962 RCE 45130 b 65.

The Department shall refer any alleged violation of these provisionprovisions for the purpose of criminal investigation and prosecution to local law enforcement or the Illinois State Police and to the State’s Attorney in the county within which the violation occurredoccurred. or the Illinois Attorney General’s office.

HB4844 Engrossed - 15 - LRB095 18962 RCE 45130 b The Department shall also refer any information it receives that appears to violate the Humane Care for Animals Act for criminal investigation and prosecution to the Illinois State Police and to the State’s Attorney in the county within which the violation occurredoccurred. or the Illinois Attorney General’s office.

(510 ILCS 72/165 rep.) Section 25.15.

HB4844 - 30 - LRB095 18962 RCE 45130 b Section 30.

The Illinois Controlled Substances Act is amended by changing Section 102 as follows:

(720 ILCS 570/102) (from Ch.

56 1/2, par.

1102) Sec.

102.

Definitions.

As used in this Act, unless the context otherwise requires:

(a) "Addict" means any person who habitually uses any drug, chemical, substance or dangerous drug other than alcohol so as to endanger the public morals, health, safety or welfare or who is so far addicted to the use of a dangerous drug or controlled substance other than alcohol as to have lost the power of self control with reference to his addiction.

(b) "Administer" means the direct application of a controlled substance, whether by injection, inhalation, ingestion, or any other means, to the body of a patient, research subject, or animal (as defined by the Humane Animal Euthanasia in Animal Shelters Act) by:

(1) a practitioner (or, in his presence, by his authorized agent), (2) the patient or research subject at the lawful direction of the practitioner, or (3) a euthanasia technician as defined by the Humane Animal Euthanasia in Animal Shelters Act.

(c) "Agent" means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or HB4844 - 31 - LRB095 18962 RCE 45130 b dispenser.

It does not include a common or contract carrier, public warehouseman or employee of the carrier or warehouseman.

(c-1) "Anabolic Steroids" means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes:

(i) boldenone, (ii) chlorotestosterone, (iii) chostebol, (iv) dehydrochlormethyltestosterone, (v) dihydrotestosterone, (vi) drostanolone, (vii) ethylestrenol, (viii) fluoxymesterone, (ix) formebulone, (x) mesterolone, (xi) methandienone, (xii) methandranone, (xiii) methandriol, (xiv) methandrostenolone, (xv) methenolone, (xvi) methyltestosterone, (xvii) mibolerone, (xviii) nandrolone, (xix) norethandrolone, (xx) oxandrolone, HB4844 - 32 - LRB095 18962 RCE 45130 b (xxi) oxymesterone, (xxii) oxymetholone, (xxiii) stanolone, (xxiv) stanozolol, (xxv) testolactone, (xxvi) testosterone, (xxvii) trenbolone, and (xxviii) any salt, ester, or isomer of a drug or substance described or listed in this paragraph, if that salt, ester, or isomer promotes muscle growth.

Any person who is otherwise lawfully in possession of an anabolic steroid, or who otherwise lawfully manufactures, distributes, dispenses, delivers, or possesses with intent to deliver an anabolic steroid, which anabolic steroid is expressly intended for and lawfully allowed to be administered through implants to livestock or other nonhuman species, and which is approved by the Secretary of Health and Human Services for such administration, and which the person intends to administer or have administered through such implants, shall not be considered to be in unauthorized possession or to unlawfully manufacture, distribute, dispense, deliver, or possess with intent to deliver such anabolic steroid for purposes of this Act.

(d) "Administration" means the Drug Enforcement Administration, United States Department of Justice, or its successor agency.

HB4844 - 33 - LRB095 18962 RCE 45130 b (e) "Control" means to add a drug or other substance, or immediate precursor, to a Schedule under Article II of this Act whether by transfer from another Schedule or otherwise.

(f) "Controlled Substance" means a drug, substance, or immediate precursor in the Schedules of Article II of this Act.

(g) "Counterfeit substance" means a controlled substance, which, or the container or labeling of which, without authorization bears the trademark, trade name, or other identifying mark, imprint, number or device, or any likeness thereof, of a manufacturer, distributor, or dispenser other than the person who in fact manufactured, distributed, or dispensed the substance.

(h) "Deliver" or "delivery" means the actual, constructive or attempted transfer of possession of a controlled substance, with or without consideration, whether or not there is an agency relationship.

(i) "Department" means the Illinois Department of Human Services (as successor to the Department of Alcoholism and Substance Abuse) or its successor agency.

(j) "Department of State Police" means the Department of State Police of the State of Illinois or its successor agency.

(k) "Department of Corrections" means the Department of Corrections of the State of Illinois or its successor agency.

(l) "Department of Professional Regulation" means the Department of Professional Regulation of the State of Illinois or its successor agency.

HB4844 - 34 - LRB095 18962 RCE 45130 b (m) "Depressant" or "stimulant substance" means:

(1) a drug which contains any quantity of (i) barbituric acid or any of the salts of barbituric acid which has been designated as habit forming under section 502 (d) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.

352 (d));

or (2) a drug which contains any quantity of (i) amphetamine or methamphetamine and any of their optical isomers;

(ii) any salt of amphetamine or methamphetamine or any salt of an optical isomer of amphetamine;

or (iii) any substance which the Department, after investigation, has found to be, and by rule designated as, habit forming because of its depressant or stimulant effect on the central nervous system;

or (3) lysergic acid diethylamide;

or (4) any drug which contains any quantity of a substance which the Department, after investigation, has found to have, and by rule designated as having, a potential for abuse because of its depressant or stimulant effect on the central nervous system or its hallucinogenic effect.

(n) (Blank).

(o) "Director" means the Director of the Department of State Police or the Department of Professional Regulation or his designated agents.

(p) "Dispense" means to deliver a controlled substance to an ultimate user or research subject by or pursuant to the HB4844 - 35 - LRB095 18962 RCE 45130 b lawful order of a prescriber, including the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for that delivery.

(q) "Dispenser" means a practitioner who dispenses.

(r) "Distribute" means to deliver, other than by administering or dispensing, a controlled substance.

(s) "Distributor" means a person who distributes.

(t) "Drug" means (1) substances recognized as drugs in the official United States Pharmacopoeia, Official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them;

(2) substances intended for use in diagnosis, cure, mitigation, treatment, or prevention of disease in man or animals;

(3) substances (other than food) intended to affect the structure of any function of the body of man or animals and (4) substances intended for use as a component of any article specified in clause (1), (2), or (3) of this subsection.

It does not include devices or their components, parts, or accessories.

(t-5) "Euthanasia agency" means an entity certified by the Department of Professional Regulation for the purpose of animal euthanasia that holds an animal control facility license or animal shelter license under the Animal Welfare Act.

A euthanasia agency is authorized to purchase, store, possess, and utilize Schedule II nonnarcotic and Schedule III nonnarcotic drugs for the sole purpose of animal euthanasia.

(t-10) "Euthanasia drugs" means Schedule II or Schedule III HB4844 - 36 - LRB095 18962 RCE 45130 b substances (nonnarcotic controlled substances) that are used by a euthanasia agency for the purpose of animal euthanasia.

(u) "Good faith" means the prescribing or dispensing of a controlled substance by a practitioner in the regular course of professional treatment to or for any person who is under his treatment for a pathology or condition other than that individual’s physical or psychological dependence upon or addiction to a controlled substance, except as provided herein:

and application of the term to a pharmacist shall mean the dispensing of a controlled substance pursuant to the prescriber’s order which in the professional judgment of the pharmacist is lawful.

The pharmacist shall be guided by accepted professional standards including, but not limited to the following, in making the judgment:

(1) lack of consistency of doctor-patient relationship, (2) frequency of prescriptions for same drug by one prescriber for large numbers of patients, (3) quantities beyond those normally prescribed, (4) unusual dosages, (5) unusual geographic distances between patient, pharmacist and prescriber, (6) consistent prescribing of habit-forming drugs.

(u-1) "Home infusion services" means services provided by a pharmacy in compounding solutions for direct administration to a patient in a private residence, long-term care facility, or HB4844 - 37 - LRB095 18962 RCE 45130 b hospice setting by means of parenteral, intravenous, intramuscular, subcutaneous, or intraspinal infusion.

(v) "Immediate precursor" means a substance:

(1) which the Department has found to be and by rule designated as being a principal compound used, or produced primarily for use, in the manufacture of a controlled substance;

(2) which is an immediate chemical intermediary used or likely to be used in the manufacture of such controlled substance;

and (3) the control of which is necessary to prevent, curtail or limit the manufacture of such controlled substance.

(w) "Instructional activities" means the acts of teaching, educating or instructing by practitioners using controlled substances within educational facilities approved by the State Board of Education or its successor agency.

(x) "Local authorities" means a duly organized State, County or Municipal peace unit or police force.

(y) "Look-alike substance" means a substance, other than a controlled substance which (1) by overall dosage unit appearance, including shape, color, size, markings or lack thereof, taste, consistency, or any other identifying physical characteristic of the substance, would lead a reasonable person to believe that the substance is a controlled substance, or (2) is expressly or impliedly represented to be a controlled HB4844 - 38 - LRB095 18962 RCE 45130 b substance or is distributed under circumstances which would lead a reasonable person to believe that the substance is a controlled substance.

For the purpose of determining whether the representations made or the circumstances of the distribution would lead a reasonable person to believe the substance to be a controlled substance under this clause (2) of subsection (y), the court or other authority may consider the following factors in addition to any other factor that may be relevant:

(a) statements made by the owner or person in control of the substance concerning its nature, use or effect;

(b) statements made to the buyer or recipient that the substance may be resold for profit;

(c) whether the substance is packaged in a manner normally used for the illegal distribution of controlled substances;

(d) whether the distribution or attempted distribution included an exchange of or demand for money or other property as consideration, and whether the amount of the consideration was substantially greater than the reasonable retail market value of the substance.

Clause (1) of this subsection (y) shall not apply to a noncontrolled substance in its finished dosage form that was initially introduced into commerce prior to the initial introduction into commerce of a controlled substance in its finished dosage form which it may substantially resemble.

HB4844 - 39 - LRB095 18962 RCE 45130 b Nothing in this subsection (y) prohibits the dispensing or distributing of noncontrolled substances by persons authorized to dispense and distribute controlled substances under this Act, provided that such action would be deemed to be carried out in good faith under subsection (u) if the substances involved were controlled substances.

Nothing in this subsection (y) or in this Act prohibits the manufacture, preparation, propagation, compounding, processing, packaging, advertising or distribution of a drug or drugs by any person registered pursuant to Section 510 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.

360).

(y-1) "Mail-order pharmacy" means a pharmacy that is located in a state of the United States, other than Illinois, that delivers, dispenses or distributes, through the United States Postal Service or other common carrier, to Illinois residents, any substance which requires a prescription.

(z) "Manufacture" means the production, preparation, propagation, compounding, conversion or processing of a controlled substance other than methamphetamine, either directly or indirectly, by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, and includes any packaging or repackaging of the substance or labeling of its container, except that this term does not include:

(1) by an ultimate user, the preparation or compounding HB4844 - 40 - LRB095 18962 RCE 45130 b of a controlled substance for his own use;

or (2) by a practitioner, or his authorized agent under his supervision, the preparation, compounding, packaging, or labeling of a controlled substance:

(a) as an incident to his administering or dispensing of a controlled substance in the course of his professional practice;

or (b) as an incident to lawful research, teaching or chemical analysis and not for sale.

(z-1) (Blank).

(aa) "Narcotic drug" means any of the following, whether produced directly or indirectly by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:

(1) opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate;

(2) any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in clause (1), but not including the isoquinoline alkaloids of opium;

(3) opium poppy and poppy straw;

(4) coca leaves and any salts, compound, isomer, salt of an isomer, derivative, or preparation of coca leaves including cocaine or ecgonine, and any salt, compound, isomer, derivative, or preparation thereof which is HB4844 - 41 - LRB095 18962 RCE 45130 b chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves which do not contain cocaine or ecgonine (for the purpose of this paragraph, the term "isomer" includes optical, positional and geometric isomers).

(bb) "Nurse" means a registered nurse licensed under the Nurse Practice Act.

(cc) (Blank).

(dd) "Opiate" means any substance having an addiction forming or addiction sustaining liability similar to morphine or being capable of conversion into a drug having addiction forming or addiction sustaining liability.

(ee) "Opium poppy" means the plant of the species Papaver somniferum L., except its seeds.

(ff) "Parole and Pardon Board" means the Parole and Pardon Board of the State of Illinois or its successor agency.

(gg) "Person" means any individual, corporation, mail-order pharmacy, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other entity.

(hh) "Pharmacist" means any person who holds a license or certificate of registration as a registered pharmacist, a local registered pharmacist or a registered assistant pharmacist under the Pharmacy Practice Act.

(ii) "Pharmacy" means any store, ship or other place in HB4844 - 42 - LRB095 18962 RCE 45130 b which pharmacy is authorized to be practiced under the Pharmacy Practice Act.

(jj) "Poppy straw" means all parts, except the seeds, of the opium poppy, after mowing.

(kk) "Practitioner" means a physician licensed to practice medicine in all its branches, dentist, optometrist, podiatrist, veterinarian, scientific investigator, pharmacist, physician assistant, advanced practice nurse, licensed practical nurse, registered nurse, hospital, laboratory, or pharmacy, or other person licensed, registered, or otherwise lawfully permitted by the United States or this State to distribute, dispense, conduct research with respect to, administer or use in teaching or chemical analysis, a controlled substance in the course of professional practice or research.

(ll) "Pre-printed prescription" means a written prescription upon which the designated drug has been indicated prior to the time of issuance.

(mm) "Prescriber" means a physician licensed to practice medicine in all its branches, dentist, optometrist, podiatrist or veterinarian who issues a prescription, a physician assistant who issues a prescription for a Schedule III, IV, or V controlled substance in accordance with Section 303.05 and the written guidelines required under Section 7.5 of the Physician Assistant Practice Act of 1987, or an advanced practice nurse with prescriptive authority delegated under HB4844 - 43 - LRB095 18962 RCE 45130 b Section 65-40 of the Nurse Practice Act and in accordance with Section 303.05 and a written collaborative agreement under Section 65-35 of the Nurse Practice Act.

(nn) "Prescription" means a lawful written, facsimile, or verbal order of a physician licensed to practice medicine in all its branches, dentist, podiatrist or veterinarian for any controlled substance, of an optometrist for a Schedule III, IV, or V controlled substance in accordance with Section 15.1 of the Illinois Optometric Practice Act of 1987, of a physician assistant for a Schedule III, IV, or V controlled substance in accordance with Section 303.05 and the written guidelines required under Section 7.5 of the Physician Assistant Practice Act of 1987, or of an advanced practice nurse with prescriptive authority delegated under Section 65-40 of the Nurse Practice Act who issues a prescription for a Schedule III, IV, or V controlled substance in accordance with Section 303.05 and a written collaborative agreement under Section 65-35 of the Nurse Practice Act.

(oo) "Production" or "produce" means manufacture, planting, cultivating, growing, or harvesting of a controlled substance other than methamphetamine.

(pp) "Registrant" means every person who is required to register under Section 302 of this Act.

(qq) "Registry number" means the number assigned to each person authorized to handle controlled substances under the laws of the United States and of this State.

HB4844 - 44 - LRB095 18962 RCE 45130 b (rr) "State" includes the State of Illinois and any state, district, commonwealth, territory, insular possession thereof, and any area subject to the legal authority of the United States of America.

(ss) "Ultimate user" means a person who lawfully possesses a controlled substance for his own use or for the use of a member of his household or for administering to an animal owned by him or by a member of his household.

(Source:

P.A.

94-556, eff.

9-11-05;

95-242, eff.

1-1-08;

95-639, eff.

10-5-07;

95-689, eff.

10-29-07;

revised 11-19-07.) Section 95.

No acceleration or delay.

Where this Act makes changes in a statute that is represented in this Act by text that is not yet or no longer in effect (for example, a Section represented by multiple versions), the use of that text does not accelerate or delay the taking effect of (i) the changes made by this Act or (ii) provisions derived from any other Public Act.